HROW (Harrow Health, Inc.) Stock Financials & Earnings | Market Cap Arena

HROW (Harrow Health, Inc.) Stock Financials & Earnings | Market Cap Arena

HROWHarrow Health, Inc.

Mkt Cap$1B

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Revenue (TTM)$272M

Net Income (TTM)-$5M

EPS (TTM)-$0.16

Free Cash Flow (TTM)$73M

Gross Margin75.1%

Op. Margin11.2%

Net Margin-1.9%

FCF Margin26.8%

P/S Ratio (TTM)5.0x

P/E Ratio (TTM)—

YoY Rev Growth+36.4%

Employees—

Earnings Reports

Next: Q1 2026 · Mar 26

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$26M	$18M	$1M
Q2 23	$33M	$23M	$2M
Q3 23	$34M	$24M	$2M
Q4 23	$36M	$25M	-$5M
Q1 24	$35M	$24M	-$7M
Q2 24	$49M	$36M	$2M
Q3 24	$49M	$37M	$1M
Q4 24	$67M	$53M	$13M
Q1 25	$48M	$32M	-$11M
Q2 25	$64M	$48M	$11M
Q3 25	$72M	$54M	$15M
Q4 25	$89M	$71M	$16M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	14.7x	—
Q2 23	13.3x	—
Q3 23	11.9x	—
Q4 23	10.5x	—
Q1 24	9.8x	—
Q2 24	8.8x	—
Q3 24	8.1x	—
Q4 24	6.8x	—
Q1 25	6.4x	—
Q2 25	6.0x	—
Q3 25	5.5x	—
Q4 25	5.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$8M	-$9M
Q2 23	$5M	$3M
Q3 23	-$1M	-$21M
Q4 23	$9M	$8M
Q1 24	-$5M	-$5M
Q2 24	-$3M	-$3M
Q3 24	$3M	$2M
Q4 24	-$18M	-$55M
Q1 25	$20M	$19M
Q2 25	-$803K	-$969K
Q3 25	$17M	$16M
Q4 25	$39M	$38M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$496K
Q2 23	$1M
Q3 23	$20M
Q4 23	$203K
Q1 24	$92K
Q2 24	$344K
Q3 24	$604K
Q4 24	$38M
Q1 25	$212K
Q2 25	$166K
Q3 25	$210K
Q4 25	$548K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+18.0%	+24.3%
Q2 23	+43.5%	+43.8%
Q3 23	+50.1%	+41.9%
Q4 23	+78.8%	+86.5%
Q1 24	+32.5%	+66.8%
Q2 24	+46.2%	+52.4%
Q3 24	+43.8%	+47.4%
Q4 24	+83.8%	+30.8%
Q1 25	+38.3%	+42.3%
Q2 25	+30.2%	+10.4%
Q3 25	+45.4%	+18.7%
Q4 25	+33.3%	+36.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$2M	6.3%
Q2 23	$5M	16.2%
Q3 23	$4M	13.1%
Q4 23	$4M	11.5%
Q1 24	$4M	12.1%
Q2 24	$4M	8.7%
Q3 24	$4M	8.9%
Q4 24	$5M	7.2%
Q1 25	$5M	9.5%
Q2 25	$875K	1.4%
Q3 25	$3M	4.6%
Q4 25	$10M	11.2%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$734K	—
Q2 23	$1M	—
Q3 23	$1M	—
Q4 23	$3M	—
Q1 24	$2M	—
Q2 24	$3M	—
Q3 24	$2M	—
Q4 24	$5M	—
Q1 25	$3M	—
Q2 25	$3M	—
Q3 25	$3M	—
Q4 25	$12M	$43M

Revenue Segments

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$19M	$8M	$27M
Q2 23	$23M	$7M	$30M
Q3 23	$66M	$8M	$74M
Q4 23	$74M	$9M	$83M
Q1 24	$69M	$7M	$76M
Q2 24	$71M	$0	$71M
Q3 24	$73M	$0	$73M
Q4 24	$47M	$0	$47M
Q1 25	$67M	$0	$67M
Q2 25	$53M	$3M	$56M
Q3 25	$74M	$0	$74M
Q4 25	$73M	$0	$73M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	30M	+2.9%
Q2 23	30M	+0.6%
Q3 23	34M	+12.5%
Q4 23	35M	+3.2%
Q1 24	35M	+0.3%
Q2 24	36M	+0.4%
Q3 24	36M	+0.2%
Q4 24	36M	+0.3%
Q1 25	36M	+0.1%
Q2 25	39M	+8.5%
Q3 25	39M	+0.1%
Q4 25	37M	-5.4%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$26K	64
FY 15	$87K	112
FY 16	$138K	144
FY 17	$209K	128
FY 18	$309K	134
FY 19	$385K	133
FY 20	$391K	125
FY 21	$398K	182
FY 22	$408K	217
FY 23	$413K	315
FY 24	$523K	382
FY 25	$1K	200K